Click to zoom
Product Description
Strength 400 mg/16 ml
Brand Bevazza
Active Ingredient Bevacizumab
Pharmaceutical Form sterile, clear to slightly opalescent, and colorless to pale yellow liquid concentrate for Intravenous (I.V.) Infusion.
Volume 16 ml
Packaging Type Vial
Country of Origin Made in India
Manufacturer Lupin
Warning and Precaution Not to be taken by Pregnant Women
Dosage Form 400/100 mg
Usage /Application Anti Cancer
Composition Bevacizumab Injection IP
Minimum order quantity: 50 Vial
BEVAZZA Bevacizumab (400 mg/16 mL) is a targeted monoclonal antibody (anti-angiogenic). It is administered via intravenous infusion to treat various advanced cancers by stopping tumors from creating new blood vessels to grow. Treatment must be prescribed and administered by a healthcare professional.
liketo,usa.uk.china.southkorea.russia.japan.singapore
Composition
Composition details not available.
Shipping Information
We offer reliable delivery across India and international markets. Domestic orders are typically delivered within 5-7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity.
100 mg MASTARIX Drostanolone Propionate Injection
On Request
Dapzigard-s 50 Dapagliflozin 10 mg & Sitagliptin 50 mg Tablets
On Request
100 mg Reditux 100 Rituximab Injection
On Request
420 mg Womab Pertuzumab Injection
On Request
50 mg AMBILON 50 Amphotericin B Liposome Injection
On Request
50 mg Qulip Liposomal Amphotericin B Injection
On Request
500 mg LupiximAb 500 Rituximab Injection
On Request
2 mg SAMRUCIN PL Doxorubicin Hydrochloride Liposomal Injection
On Request